Eventide Asset Management, LLC 13D and 13G filings for VYNE Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 3:23 pm Sale | 2025-09-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Eventide Asset Management, LLC | 0 0.000% | -1,849,597 (Position Closed) | Filing |
| 2025-08-14 4:49 pm Purchase | 2025-06-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Eventide Asset Management, LLC | 1,849,597 9.990% | 455,261 (+32.65%) | Filing |
| 2023-11-13 4:10 pm Purchase | 2023-11-01 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Eventide Asset Management, LLC | 1,394,336 9.990% | 1,394,336 (New Position) | Filing |